Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 10;11(6):940.
doi: 10.3390/cells11060940.

MicroRNA Roles in Cell Reprogramming Mechanisms

Affiliations
Review

MicroRNA Roles in Cell Reprogramming Mechanisms

Emilia Pascale et al. Cells. .

Abstract

Cell reprogramming is a groundbreaking technology that, in few decades, generated a new paradigm in biomedical science. To date we can use cell reprogramming to potentially generate every cell type by converting somatic cells and suitably modulating the expression of key transcription factors. This approach can be used to convert skin fibroblasts into pluripotent stem cells as well as into a variety of differentiated and medically relevant cell types, including cardiomyocytes and neural cells. The molecular mechanisms underlying such striking cell phenotypes are still largely unknown, but in the last decade it has been proven that cell reprogramming approaches are significantly influenced by non-coding RNAs. Specifically, this review will focus on the role of microRNAs in the reprogramming processes that lead to the generation of pluripotent stem cells, neurons, and cardiomyocytes. As highlighted here, non-coding RNA-forced expression can be sufficient to support some cell reprogramming processes, and, therefore, we will also discuss how these molecular determinants could be used in the future for biomedical purposes.

Keywords: cardiac reprogramming; iPSCs; miRNAs; neuronal reprogramming; non-coding RNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
miRNAs involved in iPSC reprogramming and direct reprogramming to neurons and cardiomyocytes. The image shows miRNAs with a promoter role (in green) and others with an inhibitory role (in red) involved in the process of converting somatic cells into iPSCs and those miRNAs (in green) that promote the direct conversion of somatic cells into cardiomyocytes and neurons. These miRNAs can be used to improve the reprogramming efficiency.

References

    1. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. doi: 10.1016/j.cell.2006.07.024. - DOI - PubMed
    1. Shi Y., Inoue H., Wu J.C., Yamanaka S. Induced pluripotent stem cell technology: A decade of progress. Nat. Rev. Drug Discov. 2017;16:115–130. doi: 10.1038/nrd.2016.245. - DOI - PMC - PubMed
    1. Peng J., Zeng X. The role of induced pluripotent stem cells in regenerative medicine: Neurodegenerative diseases. Stem Cell Res. Ther. 2011;2:32. doi: 10.1186/scrt73. - DOI - PMC - PubMed
    1. Gunaseeli I., Doss M.X., Antzelevitch C., Hescheler J., Sachinidis A. Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Curr. Med. Chem. 2010;17:759–766. doi: 10.2174/092986710790514480. - DOI - PMC - PubMed
    1. Lassar A.B., Paterson B.M., Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell. 1986;47:649–656. doi: 10.1016/0092-8674(86)90507-6. - DOI - PubMed

Publication types

MeSH terms